In vitro activity of tigecycline and resistance mechanisms due to efflux pump production in Gram negative isolates, in Portugal
Background: Tigecycline is increasingly used to treat infections caused by Gram negative isolates, because these bacteria express multidrug-resistance (MDR) phenotypes in an escalating frequency. Thus, this study aimed: 1) to correlate mediated β-lactam and fluoroquinolone resistance mechanisms (RMs...
| Autor principal: | |
|---|---|
| Outros Autores: | , , , , |
| Formato: | conferenceObject |
| Idioma: | eng |
| Publicado em: |
2017
|
| Assuntos: | |
| Texto completo: | http://hdl.handle.net/10400.18/4219 |
| País: | Portugal |
| Oai: | oai:repositorio.insa.pt:10400.18/4219 |